We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
LSB Industries
LXU
$822M
| $3.98M | 0.01% |
403,762
-205,703
| -34% | -$1.97M |
|
752
Acrivon Therapeutics
ACRV
$78.4M
| $3.95M | 0.01% |
304,411
-309,214
| -50% | -$3.74M |
|
753
Oracle
ORCL
$424B
| $3.94M | 0.01% |
33,122
+1,467
| +5% | +$152K |
|
754
Inspired Entertainment
INSE
$132M
| $3.92M | 0.01% |
266,815
-6,542
| -2% | -$88.5K |
|
755
Manchester United
MANU
$3.44B
| $3.9M | 0.01% |
160,000
+35,000
| +28% | +$725K |
|
756
LendingTree
TREE
$376M
| $3.9M | 0.01% |
176,215
-93,468
| -35% | -$1.99M |
|
757
Pediatrix Medical
MD
$2.17B
| $3.88M | 0.01% |
272,863
+61,864
| +29% | +$869K |
|
|
LPSN
758
DELISTED
LivePerson
LPSN
| $3.87M | 0.01% |
57,007
+34,733
| +156% | +$2.25M |
|
|
BIG
759
DELISTED
Big Lots, Inc.
BIG
| $3.86M | 0.01% |
437,501
+271,959
| +164% | +$2.31M |
|
|
DOOR
760
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $3.85M | 0.01% |
37,545
+34,013
| +963% | +$3.19M |
|
|
VGR
761
DELISTED
Vector Group Ltd.
VGR
| $3.85M | 0.01% |
300,195
-6,368
| -2% | -$78.5K |
|
762
Advanced Energy
AEIS
$10B
| $3.84M | 0.01% |
34,436
-413
| -1% | -$39.4K |
|
763
8x8 Inc
EGHT
$264M
| $3.83M | 0.01% |
906,426
-296,493
| -25% | -$1.07M |
|
764
BrightView Holdings
BV
$1.01B
| $3.81M | 0.01% |
+530,787
| New | +$3.35M |
|
765
Cigna
CI
$76.3B
| $3.76M | 0.01% |
13,403
+4,536
| +51% | +$1.18M |
|
766
Prestige Consumer Healthcare
PBH
$2.21B
| $3.75M | 0.01% |
63,088
-36,754
| -37% | -$2.2M |
|
767
TTM Technologies
TTMI
$11.8B
| $3.73M | 0.01% |
268,527
-46,467
| -15% | -$600K |
|
768
Lockheed Martin
LMT
$123B
| $3.72M | 0.01% |
8,080
+3,594
| +80% | +$1.67M |
|
|
NEE.PRR
769
DELISTED
NextEra Energy, Inc. 6.926% Corporate Units
NEE.PRR
| $3.71M | 0.01% |
82,000
| – | – |
|
770
Thor Industries
THO
$3.71B
| $3.71M | 0.01% |
35,855
+4,114
| +13% | +$347K |
|
|
AESC
771
DELISTED
The AES Corporation
AESC
| $3.7M | 0.01% |
45,336
| – | – |
|
772
ResMed
RMD
$33.1B
| $3.7M | 0.01% |
16,935
+5,236
| +45% | +$1.17M |
|
773
Tradeweb Markets
TW
$21.4B
| $3.69M | 0.01% |
53,939
-9,216
| -15% | -$653K |
|
|
CADE
774
DELISTED
Cadence Bank
CADE
| $3.69M | 0.01% |
187,696
+762
| +0.4% | +$15K |
|
775
Ashland
ASH
$3.22B
| $3.68M | 0.01% |
42,400
-4,436
| -9% | -$410K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.